FYI from the NHLBI Index

 

January 2013: Vol. 13, Issue 3
Research and Resources


NHLBI Research Initiatives

  • Ancillary Studies in Clinical Trials (R01)
  • Functional Assays to Screen Genomic Hits (R21/R33)
  • Mechanisms of HIV-Related Lung Disease (U01)
  • Selected Topics in Transfusion Medicine
  • NHLBI Clinical Trial Pilot Studies (R34)
  • Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)
  • Comparison of Strategies to Study Pediatric Pulmonary Vascular Disease Outcomes Using Bioinformatics (U01)
  • Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
  • Mentored Career Development Award to Promote Faculty Diversity/Re-Entry in Biomedical Research (K01)

Need More Information?


NHLBI Research Initiatives

From time to time, the NHLBI invites investigators to submit grant applications or contract proposals for specific research programs. We are soliciting applications for the new programs described below. Please visit the URL listed with each program to obtain information about application dates and deadlines. For full details of these and other current research initiatives, visit www.nhlbi.nih.gov/funding/inits/index.htm.


Ancillary Studies in Clinical Trials (R01)

  • Initiative Number: RFA-HL-14-004
  • Objective: Conduct time-sensitive ancillary studies related to heart, lung, and blood diseases and sleep disorders in conjunction with ongoing clinical trials and other large clinical studies.

Functional Assays to Screen Genomic Hits (R21/R33)

  • Initiative Number: RFA-HL-13-027
  • Objective: Develop and implement functional analyses of identified genetic variations using inexpensive in vitro or animal model systems.

Mechanisms of HIV-Related Lung Disease (U01)

  • Initiative Number: RFA-HL-13-026 and RFA-HL-13-028
  • Objective: Define cellular and molecular events underlying the pathogenesis of HIV-associated lung diseases using biospecimens and clinical data from HIV-infected patients and controls.

Selected Topics in Transfusion Medicine (R01/R21)

  • Initiative Number: PAR-13-025 and PAR-13-026
  • Objective: Encourage exploratory/developmental research in blood banking and transfusion medicine.

NHLBI Clinical Trial Pilot Studies (R34)

  • Initiative Number: PAR-13-002
  • Objective: Encourage pilot studies that will obtain data to fill the gaps in scientific knowledge needed to develop a competitive full-scale clinical trial.

Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)

  • Initiative Number: RFA-HL-13-025
  • Objective: Support a multi-component research program to address multiple research aspects of trauma-induced coagulopathy.

Comparison of Strategies to Study Pediatric Pulmonary Vascular Disease Outcomes Using Bioinformatics (U01)

  • Initiative Number: RFA-HL-14-005
  • Objective: Compare the ability of two data sources, electronic health records and traditional prospective patient-based clinical and research data, to answer research questions regarding the natural history, longitudinal outcomes, and phenotypes of therapeutic response for pediatric pulmonary vascular disease.

Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)

  • Initiative Number: PAR-13-009
  • Objective: Stimulate well-focused secondary analyses of existing human datasets to test innovative hypotheses concerning diseases/conditions relevant to the NHLBI mission.

Mentored Career Development Award to Promote Faculty Diversity/Re-Entry in Biomedical Research (K01)

  • Initiative Number: RFA-HL-13-019
  • Objective: Promote diversity and re-entry in the biomedical, behavioral, clinical, and social sciences research workforce.






Need More Information?

We are always interested in receiving comments and suggestions from the community. If you or your organizations have questions for me or for the Institute, please contact me at gary.gibbons@nih.gov.

Gary H. Gibbons, M.D.
Director, NHLBI

For information on specific issues, the following contacts may be helpful:

For health related questions and publications, please contact the trained information specialists at the NHLBI Information Center (NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105, Bethesda, MD 20824-0105.

For communications pertaining to NHLBI policies and priorities, contact the NHLBI Office of Public Liaison, (nhlbi.listens@nih.gov).

For additional information regarding NHLBI events, consult the references provided or NHLBI Calendar. Most other NIH Institutes and Centers also maintain calendars on their websites. Links to their Web pages are at NIH Institutes, Centers, and Offices.

For Web related matters pertaining to the online version of the FYI from the NHLBI, contact the FYI from the NHLBI's Web Editor.



Please send us your feedback, comments, and questions by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.

Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon